Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ontogen Corp.

www.ontogen.com

Latest From Ontogen Corp.

Solvo Biotechnology Inc.

Hungarian start-up Solvo Biotechnology is attempting to create therapeutics to treat multidrug resistance--a phenomenon describing a cancer cell's ability to resist the toxicity of chemotherapies. Solvo is developing compounds targeting molecular pumps that expel cytotoxic drugs from cancerous cells.
BioPharmaceutical Europe

Boehringer Ingelheim Restructures for Success

Boehringer Ingelheim has restructured to emphasize partnering--both to bring in new products and technologies, and to boost its global market share. The strategy is paying off.
BioPharmaceutical Strategy

Jouvence Pharmaceuticals Inc.

Drug Discovery Tools; Genomics. Jouvence is dedicated to developing anti-aging therapies through genomics efforts. The company has licensed the LAG-1 gene, one of the first genes definitively linked to the longevity of an organism. Yeast strains in which the gene has been knocked out live 100% longer than average.
BioPharmaceutical Platform Technologies
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
  • Pharmaceuticals
  • Research, Analytical Equipment & Supplies
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Ontogen Corp.
  • Senior Management
  • Barry E Toyonaga, PhD, Pres. & CEO
    Mark Huxhold, Controller
    William C Ripka, PhD, CTO
    Jeff Lucero Riley, VP, Strategy & Corp. Dev.
  • Contact Info
  • Ontogen Corp.
    Phone: (760) 930-0100
    6451 El Camino Real
    Carlsbad, CA 92009
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register